Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pennon Group PLC Share Issue/Capital Change 2019

Feb 26, 2019

4705_rns_2019-02-26_19549a48-448b-48ab-8532-b3aec5d02af5.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1846R

Pennon Group PLC

26 February 2019

BLOCK LISTING SIX MONTHLY RETURN

Date:  26 February 2019

Name of applicant: PENNON GROUP PLC
Name of scheme: PENNON GROUP SHARESAVE SCHEME
Period of return: From: 01/08/18 To: 31/01/19
Balance of unallotted securities under scheme(s) from previous return: 83,415
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 772,954
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 706,352
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 150,017
Name of applicant: PENNON GROUP PLC
Name of scheme: PENNON GROUP EXECUTIVE SHARE OPTION SCHEME
Period of return: From: 01/08/18 To: 31/01/19
Balance of unallotted securities under scheme(s) from previous return: 14,663
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): NIL
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 14,663
Name of contact: S Massie - Interim Deputy Company Secretary
Telephone number of contact: 01392 443721

26 February 2019

www.pennon-group.co.uk

End transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRLLFVEFFIRFIA